Please use this identifier to cite or link to this item:
https://digital.lib.ueh.edu.vn/handle/UEH/60077
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Muhammad Sadiq | en_US |
dc.contributor.other | Quyen Ha Tran | en_US |
dc.date.accessioned | 2020-05-04T06:35:19Z | - |
dc.date.available | 2020-05-04T06:35:19Z | - |
dc.date.issued | 2020 | - |
dc.identifier.issn | 0975-8453 (Print), 0976-2779 (Online) | - |
dc.identifier.uri | http://digital.lib.ueh.edu.vn/handle/UEH/60077 | - |
dc.description.abstract | This study aims to identify the level of awareness in the Nigerian pharmaceutical industry in terms of environmental accounting. We discuss the laws and regulation related to environmental accounting with respect to the Nigerian pharmaceutical industry. We use two different methods of investigation namely questioner and content analysis in order to maximize the reliability of research. We receive 40 valid questionnaires out of 50, then investigate the requirement of environmental accounting in different aspect such as availability of accounting information system, availability of environmental information system, awareness of environmental damage among the employees, awareness of environmental accounting standard, and commitment with environmental standards. The investigated results indicate that the pharmaceutical industry of Nigeria is well aware of environmental responsibility and struggling to implement and practice environmental accounting standard. | en_US |
dc.format | Portable Document Format (PDF) | en_US |
dc.language.iso | en | en_US |
dc.publisher | Medknow Publications and Media Pvt. Ltd | en_US |
dc.relation.ispartof | Systematic Reviews in Pharmacy | en_US |
dc.relation.ispartofseries | Vol. 11, Issue 1 | en_US |
dc.rights | Systematic Reviews in Pharmacy | en_US |
dc.subject | Environmental accounting | en_US |
dc.subject | Questionnaires | en_US |
dc.subject | Awareness of environmental damage | en_US |
dc.title | Environmental accounting perception: evidence from nigerian pharmaceutical firms | en_US |
dc.type | Journal Article | en_US |
dc.identifier.doi | https://doi.org/10.5530/srp.2020.1.39 | - |
dc.format.firstpage | 303 | en_US |
dc.format.lastpage | 309 | en_US |
ueh.JournalRanking | Scopus | en_US |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.fulltext | Only abstracts | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
Appears in Collections: | INTERNATIONAL PUBLICATIONS |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.